2021 Achondroplasia Research Conference
The Chandler Project hosted the 3rd Annual Achondroplasia Research Conference, a hybrid event, on July 2 & 3 in Baltimore, Maryland. Over 100 attendees from 21 countries were able to hear from and interact with world-renowned physicians and researchers from: Nemours/Alfred I. duPont Hospital for Children, Children's National Hospital, Murdoch Children's Research Institute, International Center for Limb Lengthening, BioMarin Pharmaceutical, Inc., Pfizer, Ascendis Pharma, and QED therapeutics.
This is the only event in North America to learn about new research and developments, both pharmaceutical and surgical, for the treatment of achondroplasia, and now other forms of dwarfism and skeletal dysplasia, in a safe environment without any fear of conflict or controversy. Check back soon for information on the 2022 conference!
Image – L to R: Shawn C. Standard, MD, FAAOS, Chandler Crews, John E. Herzenberg, MD, FRCSC, FAAOS
Continue >The Chandler Project (TCP) provides advocacy, awareness, research, and support to those affected by achondroplasia (ACH) & other forms of skeletal dysplasia.
Advocacy
Awareness
Research
